ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF PSEUDOMONAS AERUGINOSA ISOLATED AT HAI PHONG INTERNATIONAL HOSPITAL IN 2023

Thị Nga Lưu, Văn An Nguyễn , Nguyễn Minh Hoa Lê , Quang Đôn Trần, Hạ Long Hải Lê

Main Article Content

Abstract

Objective: Antimicrobial resistance of Pseudomonas aeruginosa has recently emerged as a significant concern in the context of infections. Materials and methods: This cross-sectional study aimed to investigate the prevalence and antimicrobial susceptibility patterns of P. aeruginosa isolated at Hai Phong International General Hospital in 2023. Results: The result revealed that the prevalence of P. aeruginosa was 1,3% (65 out of 4853), with the respiratory tract being the most frequent source of isolates. P. aeruginosa showed the highest susceptibility to piperacillin-tazobactam (78,5%). Notably, a significant portion (26,2%) of P. aeruginosa displayed multidrug resistance, with all being reduced susceptibility to ceftazidime, cefepime, ciprofloxacin, levofloxacin and imipenem. Conclusions: This study underscored the common occurrence of Pseudomonas aeruginosa and its increasing reduced susceptibility to commonly used antibiotics. The study emphasizes the importance of infection control and judicious antibiotic use to mitigate the spread of antibiotic-resistant bacterial strains.

Article Details

References

Nguyễn Thị Đoan Trinh và cộng sự (2023). Đặc điểm gây bệnh và tính kháng kháng sinh của Pseudomonas aeruginosa tại Bệnh viện C Đà Nẵng. Tạp chí Y Dược học Cần Thơ. Số 58: tr. 159–166.
2. Nguyễn Thị Huyền và cộng sự (2021). Mức độ kháng sinh của Pseudomonas aeruginosa phân lập tại bệnh viện Trung Ương Thái Nguyên năm 2017-2021. Tạp chí Y học Việt Nam. 523(1): tr. 115–119.
3. A. Samad, T. Ahmed, A. Rahim, A. Khalil, và I. Ali (2017). Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients of respiratory tract infections in a Tertiary Care Hospital, Peshawar. Pakistan Journal of Medical Sciences. 33(3): p.670–674.
4. Centers for Disease Control and Prevention (2019). Antibiotic resistance threats in the United States 2019 (CDC’s 2019). The 2019 AR Threats report is available online at www.cdc.gov/ DrugResistance/Biggest-Threats.html.
5. Dan Reynolds, Marin Kollef (2021). The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update. Drugs. 81(18): p. 2117–2131.
6. Florence Depardieu et al (2007). Modes and Modulations of Antibiotic Resistance Gene Expression. American Society for Microbiology. 20(1): p. 79-114.
7. Magiorakos et al (2012). Multidrug- resistant, extensivelydrug-resistant and pandrug- resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 18(3): p. 268–281.
8. Tien Viet Dung Vu et al (2021). Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016- 2017. Antimicrob Resist Infect Control. 10(78).